Gliclazide Mr Tablets 30mg, 60mg Tablet

Gliclazide Mr Tablets 30mg, 60mg Tablet

Product Name :

Salbutamol Tablets Bp 2 Mg Tablet

Available Strength :

Salbutamol 2 mg

Packing :

10x10 Alu-Pvc Blister / As per your requirement

Pack Insert/ Leaflet :

Available upon request

Therapeutical Use :

Bronchodilator therapy

Production Capacity :

10 Million Tablets/Month

Description:

What is Gliclazide Mr Tablets 30mg, 60mg Tablet?

Gliclazide MR Tablets 30 mg and 60 mg contain gliclazide, an oral antidiabetic medicine supplied as a modified-release tablet. Gliclazide is used in the management of type 2 diabetes mellitus to help control elevated blood glucose levels as part of an appropriate dietary, lifestyle, and medical treatment plan.

Uses / Indications

Gliclazide MR tablets may be indicated for:

  • Management of type 2 diabetes mellitus
  • Control of elevated blood glucose levels
  • Glycemic management when dietary and lifestyle measures alone are insufficient
  • Diabetes treatment as directed by a qualified healthcare professional

Benefits

  • Helps improve blood glucose control in appropriate patients with type 2 diabetes.
  • Supports management of elevated blood glucose levels.
  • Modified-release formulation is designed to provide prolonged release of gliclazide.
  • May be incorporated into an individualized diabetes management plan.

Side Effects

Common Side Effects

Possible side effects may include:

  • Hypoglycemia
  • Nausea
  • Abdominal discomfort
  • Headache
  • Constipation
  • Weight gain

Less Common or Serious Side Effects

Less common or serious reactions may include severe or prolonged hypoglycemia, allergic reactions, liver-related abnormalities, blood disorders, and serious skin reactions.

Severe low blood glucose may cause confusion, unusual behavior, loss of consciousness, or seizures and requires immediate medical attention.

How Does It Work?

Gliclazide belongs to the sulfonylurea class of oral antidiabetic medicines.

It primarily works by stimulating pancreatic beta cells to release insulin. Increased insulin secretion can help reduce blood glucose levels in people with type 2 diabetes who retain functioning insulin-producing pancreatic cells.

The modified-release formulation is designed to release gliclazide gradually over time according to the product formulation.

Dosage Guidelines

The appropriate dose depends on blood glucose levels, response to treatment, dietary intake, age, kidney and liver function, other medicines, and the individual’s diabetes management plan.

  • Take the tablet exactly as prescribed.
  • Follow the approved product instructions regarding administration with meals.
  • Swallow the modified-release tablet whole with water.
  • Do not crush, chew, or break the tablet unless specifically permitted by the approved product information.
  • Monitor blood glucose as advised.
  • Do not double the dose after a missed dose.
  • If an overdose is suspected, seek immediate medical attention or contact an appropriate poison-control or emergency medical service.

The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

When Not to Use

Gliclazide MR may not be appropriate in certain situations, including:

  • Known hypersensitivity to gliclazide or related sulfonylureas.
  • Type 1 diabetes mellitus.
  • Diabetic ketoacidosis or diabetic coma.
  • Severe hypoglycemia.
  • Certain severe kidney or liver conditions, depending on clinical assessment.
  • Use with certain medicines where the combination is contraindicated according to the approved product information.

A qualified healthcare professional should determine whether gliclazide is appropriate for the individual patient.

Drug / Product Interactions

Gliclazide may interact with medicines that affect blood glucose levels or increase the risk of hypoglycemia.

Relevant medicines and substances may include:

  • Insulin and other antidiabetic medicines
  • Certain antibiotics and antifungal medicines
  • Beta-blockers
  • Anticoagulants
  • Corticosteroids
  • Certain diuretics
  • Alcohol

The complete medication and supplement list should be reviewed by a healthcare professional before treatment.

Safety Advice

  • Monitor blood glucose according to the prescribed diabetes management plan.
  • Be aware of symptoms of hypoglycemia, including sweating, trembling, hunger, dizziness, weakness, confusion, and headache.
  • Maintain regular meals according to professional dietary advice.
  • Avoid excessive alcohol consumption because it can affect blood glucose control and hypoglycemia risk.
  • Inform the healthcare professional if you are pregnant, planning pregnancy, or breastfeeding.
  • Patients with kidney or liver impairment may require additional medical supervision.
  • Older adults may require careful monitoring because of increased sensitivity to hypoglycemia.
  • Use caution with driving or operating machinery if symptoms of low blood glucose occur.

General Instructions

  • Take gliclazide MR according to the prescribed schedule.
  • Follow the approved instructions concerning meal timing.
  • Swallow the modified-release tablet whole.
  • Do not crush, chew, or alter the tablet unless specifically permitted.
  • Maintain appropriate dietary and lifestyle measures.
  • Monitor blood glucose as recommended.
  • Do not change the dose or discontinue treatment without professional guidance.

Special Dietary / Lifestyle Tips

  • Follow the individualized dietary plan recommended for diabetes management.
  • Maintain regular meal timing where advised.
  • Limit excessive consumption of refined sugars and highly processed foods.
  • Maintain appropriate physical activity according to individual medical advice.
  • Stay adequately hydrated.
  • Avoid excessive alcohol consumption.
  • Monitor blood glucose regularly as recommended.

Comparison with Other Treatments

Gliclazide is a sulfonylurea used for type 2 diabetes management. Other treatment approaches may include metformin, other oral or injectable glucose-lowering medicines, insulin, dietary measures, physical activity, or combinations of therapies.

Treatment selection depends on factors such as blood glucose control, kidney and liver function, age, risk of hypoglycemia, other medical conditions, and concurrent medicines.

Precautions & Warnings

  • Gliclazide can cause hypoglycemia, which may occasionally be severe.
  • The risk may increase when meals are skipped, food intake is inadequate, alcohol is consumed, or other glucose-lowering medicines are used.
  • Kidney or liver impairment may affect glucose control and the risk of hypoglycemia.
  • Blood glucose should be monitored according to the prescribed plan.
  • Seek medical attention for severe, recurrent, or prolonged episodes of low blood glucose.
  • Inform healthcare professionals before surgery or major changes in diet or physical activity.
  • Pregnancy and breastfeeding require appropriate professional assessment before treatment.

Can I Use It With Other Medicines?

Generally Compatible With

Gliclazide MR may be used with selected medicines as part of an individualized diabetes management plan, including certain other glucose-lowering treatments when clinically appropriate.

Use With Caution / Avoid

Particular caution may be required with insulin, other antidiabetic medicines, beta-blockers, certain antibiotics, antifungal medicines, corticosteroids, anticoagulants, diuretics, and alcohol because these may alter blood glucose control or the risk of hypoglycemia.

A qualified healthcare professional should review all current medicines before use.

Storage

Store according to the storage conditions stated on the approved product label and package insert.

  • Keep the tablets in their original packaging.
  • Protect from moisture and unsuitable storage conditions.
  • Keep out of reach of children.
  • Do not use after the expiry date stated on the packaging.

Frequently Asked Questions

1. What is Gliclazide MR 30 mg and 60 mg used for?

Gliclazide MR is an oral antidiabetic medicine used in the management of type 2 diabetes mellitus to help control elevated blood glucose levels.

2. What does MR mean in Gliclazide MR?

MR means modified release. The formulation is designed to release gliclazide gradually according to the characteristics of the approved product.

3. Can Gliclazide MR cause low blood sugar?

Yes. Hypoglycemia is an important potential adverse effect, particularly when meals are skipped or gliclazide is combined with other glucose-lowering medicines.

4. Can Gliclazide MR tablets be crushed or chewed?

Modified-release tablets are generally intended to be swallowed whole. Do not crush or chew them unless the approved product information specifically permits it.

5. Can Gliclazide be used with other diabetes medicines?

It may be combined with other antidiabetic treatments in selected patients, but combinations should be determined and monitored by a qualified healthcare professional.

6. What should I do if I miss a dose?

Follow the approved product instructions. Do not take a double dose to compensate for a missed dose.

7. What are symptoms of low blood sugar?

Symptoms may include sweating, trembling, hunger, dizziness, weakness, headache, confusion, and changes in alertness. Severe hypoglycemia may result in seizures or loss of consciousness and requires immediate medical attention.

8. Can Gliclazide MR be used during pregnancy?

Pregnancy requires specific medical assessment before treatment. Inform the healthcare professional if you are pregnant, planning pregnancy, or breastfeeding.

Scroll to Top